Milan Lović
Research Subjects
Milan Lović has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ivan Tasic
Institute for Therapy and Rehabilitation Niska Banja
2 shared publications Svetlana Kostić
Institute for Therapy and Rehabilitation Niska Banja
2 shared publications- Dragan Djordjevic
University of Nis, Medical Faculty, Nis, Serbia
1 shared publication Dragan Đorđević
Institute for Therapy and Rehabilitation Niska Banja
1 shared publicationDušan Vulić
University of Banja Luka, School of Medicine, Banja Luka, Bosnia and Herzegovina
1 shared publicationNikola Stojanović
Faculty of Medicine University of Nis
1 shared publication
Latest Publications
- 1 January 2020
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 39 (3) , 23-26
How should we obtain a precise estimate of cardiovascular risk in asymptomatic adults?
Background. A precise estimate of cardiovascular (CV) risk in asymptomatic individuals is a key factor in the primary prevention of CV disease. Case report. In this report describe an asymptomatic individual presenting for CV status assessment. After the CV risk assessment using the SCORE risk charts and Framingham score, additional tests were performed, which provided better insight and reclassification of risk in this individual. Carotid Doppler sonography revealed plaques in the carotid arteries. Non-invasive assessment of coronary flow reserve (stress echocardiography test) demonstrated that a considerable area of the left ventricle is suffering ischemia when stressed. This was an indication for coronarography, which showed severe three-vessel coronary disease, that was later successfully treated by surgical revascularization. A year after the surgery a control stress echocardiography was performed, showing a satisfactory coronary flow reserve. Conclusion. A precise estimate of CV risk in asymptomatic individuals opens the road leading to early diagnosis, adequate therapy, and prevention of CV disease.
- 1 January 2020
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 39 (3) , 23-26
How should we obtain a precise estimate of cardiovascular risk in asymptomatic adults?
Background. A precise estimate of cardiovascular (CV) risk in asymptomatic individuals is a key factor in the primary prevention of CV disease. Case report. In this report describe an asymptomatic individual presenting for CV status assessment. After the CV risk assessment using the SCORE risk charts and Framingham score, additional tests were performed, which provided better insight and reclassification of risk in this individual. Carotid Doppler sonography revealed plaques in the carotid arteries. Non-invasive assessment of coronary flow reserve (stress echocardiography test) demonstrated that a considerable area of the left ventricle is suffering ischemia when stressed. This was an indication for coronarography, which showed severe three-vessel coronary disease, that was later successfully treated by surgical revascularization. A year after the surgery a control stress echocardiography was performed, showing a satisfactory coronary flow reserve. Conclusion. A precise estimate of CV risk in asymptomatic individuals opens the road leading to early diagnosis, adequate therapy, and prevention of CV disease.
- 1 January 2019
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 38 (2) , 33-37
Treatment of patients with hypertension and high cardiovascular risk
Hypertension with high cardiovascular (CV) risk is characterized by significant increase of one of the risk factors, especially cholesterol above 8 mmol/l in, for instance, familial hypercholesterolemia, or blood pressure (BP) ≥180/110 mmHg (stage III hypertension), diabetes mellitus, hypertensive left ventricular hypertrophy (LVH), moderate chronic renal failure with eGFR of 30-59 mL/min/1.73 m2 and/or calculated 10-year SCORE of 5-10%. Case report: We presented in this paper a patient with hypertension and high risk in whom diastolic hypertension, left ventricular hypertrophy, metabolic syndrome and obesity were predominant in the beginning, while diabetes mellitus prevailed in the further disease course. We presented the diagnostic protocol, as well as the risk assessment according to the European and American guidelines, and a proper selection of non-medicamentous and medicamentous therapy. The patient was treated and observed for 20 years, and the therapy based on the official hypertension guidelines was able to prevent major cardiovascular events and to suspend the progression of target organ damage in hypertension. Conclusion: Proper risk assessment in hypertensive patients, presence of risk factors and target organ damage have a decisive role in the selection of adequate therapy in hypertension. Achievement of target BP values, control of risk factors and regression of target organ damage constitute the basis of good quality of life of hypertensive patients and prevention of major cardiovascular events.
- 1 January 2019
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 38 (2) , 33-37
Treatment of patients with hypertension and high cardiovascular risk
Hypertension with high cardiovascular (CV) risk is characterized by significant increase of one of the risk factors, especially cholesterol above 8 mmol/l in, for instance, familial hypercholesterolemia, or blood pressure (BP) ≥180/110 mmHg (stage III hypertension), diabetes mellitus, hypertensive left ventricular hypertrophy (LVH), moderate chronic renal failure with eGFR of 30-59 mL/min/1.73 m2 and/or calculated 10-year SCORE of 5-10%. Case report: We presented in this paper a patient with hypertension and high risk in whom diastolic hypertension, left ventricular hypertrophy, metabolic syndrome and obesity were predominant in the beginning, while diabetes mellitus prevailed in the further disease course. We presented the diagnostic protocol, as well as the risk assessment according to the European and American guidelines, and a proper selection of non-medicamentous and medicamentous therapy. The patient was treated and observed for 20 years, and the therapy based on the official hypertension guidelines was able to prevent major cardiovascular events and to suspend the progression of target organ damage in hypertension. Conclusion: Proper risk assessment in hypertensive patients, presence of risk factors and target organ damage have a decisive role in the selection of adequate therapy in hypertension. Achievement of target BP values, control of risk factors and regression of target organ damage constitute the basis of good quality of life of hypertensive patients and prevention of major cardiovascular events.